Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

COL9A3 antibody (AA 501-528)

COL9A3 Reactivity: Human WB Host: Rabbit Polyclonal RB42519 unconjugated
Catalog No. ABIN1881221
  • Target See all COL9A3 Antibodies
    COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))
    Binding Specificity
    • 7
    • 6
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 501-528
    Reactivity
    • 30
    • 11
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Host
    • 29
    • 2
    Rabbit
    Clonality
    • 30
    • 1
    Polyclonal
    Conjugate
    • 14
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This COL9A3 antibody is un-conjugated
    Application
    • 20
    • 18
    • 4
    • 3
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This COL9A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 501-528 amino acids from the Central region of human COL9A3.
    Clone
    RB42519
    Isotype
    Ig Fraction
    Top Product
    Discover our top product COL9A3 Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Videman, Saarela, Kaprio, Näkki, Levälahti, Gill, Peltonen, Battié: "Associations of 25 structural, degradative, and inflammatory candidate genes with lumbar disc desiccation, bulging, and height narrowing." in: Arthritis and rheumatism, Vol. 60, Issue 2, pp. 470-81, (2009) (PubMed).

    Karppinen, Daavittila, Solovieva, Kuisma, Taimela, Natri, Haapea, Korpelainen, Niinimäki, Tervonen, Ala-Kokko, Männikkö: "Genetic factors are associated with modic changes in endplates of lumbar vertebral bodies." in: Spine, Vol. 33, Issue 11, pp. 1236-41, (2008) (PubMed).

    Decramer, Bascands, Schanstra: "Non-invasive markers of ureteropelvic junction obstruction." in: World journal of urology, Vol. 25, Issue 5, pp. 457-65, (2007) (PubMed).

    Virtanen, Karppinen, Taimela, Ott, Barral, Kaikkonen, Heikkilä, Mutanen, Noponen, Männikkö, Tervonen, Natri, Ala-Kokko: "Occupational and genetic risk factors associated with intervertebral disc disease." in: Spine, Vol. 32, Issue 10, pp. 1129-34, (2007) (PubMed).

  • Target
    COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))
    Alternative Name
    COL9A3 (COL9A3 Products)
    Synonyms
    DJ885L7.4.1 antibody, EDM3 antibody, IDD antibody, MED antibody, AV006866 antibody, col9a3 antibody, MGC80136 antibody, cb367 antibody, sb:cb367 antibody, wu:fa04f01 antibody, si:ch73-162j3.1 antibody, COL9A3 antibody, LOC100221007 antibody, collagen type IX alpha 3 chain antibody, collagen, type IX, alpha 3 antibody, collagen, type IX, alpha 3 L homeolog antibody, COL9A3 antibody, Col9a3 antibody, col9a3.L antibody, col9a3 antibody
    Background
    This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3.
    Molecular Weight
    63616
    NCBI Accession
    NP_001844
    UniProt
    Q14050
You are here:
Support